Top Markets
#1 Status Status +15.88%
#2 Animecoin Animecoin +4.71%
#3 Hex Trust USD Hex Trust USD +4.51%
#4 MANTRA MANTRA +2.96%
#5 Raydium Raydium +2.65%
#6 Infinity Ground Infinity Ground +2.33%
#7 Holo Holo +2.24%
#8 OmniBridge Bridged Zcash (Solana) OmniBridge Bridged Zcash (Solana) +2.03%
#9 City Boy City Boy +1.97%
#10 Zcash Zcash +1.90%
Coin of the day
Status Status
Cài đặt
Ngôn ngữ
TIếNG VIệT
Tiền tệ
USD
Chủ đề
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated

VRTX
Xếp hạng trong cổ phiếu #171
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in... Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation. Its pipeline includes VX-864 for the treatment of AAT deficiency, which is in Phase 2 clinical trial; VX-147 for the treatment of APOL1-mediated focal segmental glomerulosclerosis, or FSGS, and other serious kidney diseases which is in Phase 2 clinical trial; VX- 880, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-548, a NaV1.8 inhibitor for treatments of acute, neuropathic, musculoskeletal pain which is in Phase 2 clinical trial; and CTX001 for the treatment severe SCD and TDT which is in Phase 3 clinical trial. The company sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. It has collaborations with Affinia Therapeutics, Inc.; Arbor Biotechnologies, Inc.; CRISPR Therapeutics AG.; Kymera Therapeutics, Inc.; Mammoth Biosciences, Inc.; Moderna, Inc.; Obsidian Therapeutics, Inc.; and Skyhawk Therapeutics, Inc.; as well as Ribometrix, Inc.; Genomics plc; Merck KGaA; Darmstadt, Germany, and X-Chem, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.
Giá cổ phiếu
$451.59
Vốn hóa thị trường
$114.70B
Thay đổi (1 ngày)
-2.36%
Thay đổi (1 năm)
-11.89%
Quốc gia
US
Giao dịch Vertex Pharmaceuticals Incorporated (VRTX)

Danh mục

Healthcare
Lịch sử giá cổ phiếu của Vertex Pharmaceuticals Incorporated (VRTX)
Giá đóng cửa cao nhất: $471.98 vào 2026-03-01

Giá đóng cửa thấp nhất: $4.53 vào 1991-07-01
Lịch sử giá cổ phiếu của Vertex Pharmaceuticals Incorporated từ 1991 đến 2026
Hiệu suất giá cổ phiếu hàng năm
Năm Hiệu suất
2026 (TTM) -1.31%
2025 2.37%
2024 14.62%
2023 26.67%
2022 42.43%
2021 -7.62%
2020 4.81%
2019 31.22%
2018 16.13%
2017 90.85%
2016 -38.17%
2015 4.35%
2014 70.24%
2013 66.70%
2012 32.33%
2011 -9.21%
2010 -16.79%
2009 55.96%
2008 6.88%
2007 -37.93%
2006 48.43%
2005 145.33%
2004 17.32%
2003 -44.48%
2002 -31.43%
2001 -66.16%
2000 401.04%
1999 7.87%
1998 -12.61%
1997 -7.67%
1996 56.01%
1995 67.39%
1994 -22.39%
1993 49.41%
1992 -18.91%
1991 0.00%
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
Công ty Giá cổ phiếu Thay đổi 1năm% Quốc gia
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $37.45 -52.59%
DK
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $744.12 10.67%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $301.16 53.12%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $94.71 -40.92%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $684.77 10.45%
NL